Results of Clinical Observation to Assess the Impact of Infanetim Tech- nology Black Line Toothpaste on the Risk of Influenza and Arvi in Adults (Black-1)

Authors

  • Shimansky Shalva Levanovich Author
  • Shabalkin Pavel Igorevich Author

Keywords:

Influenza, ARVI, INFANETIM Technology Black line toothpaste

Abstract

Graphical abstract

Aim: To assess the effect of daily use of INFANETIM Technology Black line hygienic toothpaste in adults on the risk of incidence
of influenza and ARVI. Patients and methods: We conducted a controlled clinical observation BLACK-1 with the participation of volunteers over 18 years old to evaluate the effectiveness of INFANETIM Technology Black line hygienic toothpaste for reducing the incidence of SARS and influenza during November 2019 - March 2020. The observation was carried out on the basis of the dental clinic
A.I. Evdokimov Moscow State Medical University of the Ministry of Health of Russia and the Clinic of Oncoimmunology and
Cytokine Therapy LLC. 2,000 volunteers were randomly assigned to use either the INFANETIM Technology Black line hygienic
toothpaste, or the generic hygienic toothpaste daily for about 2 months. Researchers received weekly remote information on
the health status of the volunteer to track cases of respiratory diseases and their outcomes. Results: During the 8-week period, the incidence rate per 2,000 people was 70 in the INFANETIM Technology group (vs. 344 in the control group, p-value = 0.040; 95% CI 2232%). The incidence of laboratory-confirmed influenza was 31% lower in the study group (23/70) than in the control group (220/344) (P-value = 0.012; 95% CI 25-37%). In the study group, only 3 cases of hospitalization due to the development of bacterial pneumonia were registered; in the control group, complications were

References

Influenza in adults: guidelines for diagnosis, treatment, specific and non-specific prevention / A.G. Chuchalin, T.V. Sologub. SPb, 2014.

Eliakim-Raz, N., Vinograd, I., Trestioreanu, AZ., Leibovici, L., Paul, M. (2013) Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev, 2013(10): CD008983.

Kamps, BS., Homann, C., Preiser, W. (2006) Influenza report.

Clinical guidelines Influenza in adults. Non-profit corporate organization "International Association of Infection Professionals" ("ISSAI"). Ministry of Health of the Russian Federation, 2017.

https://www.who.int/ru/news-room/detail/14-12- 2017-up-to-650-000-people-die-of-respiratory-diseaseslinked-to-seasonal-flu- each-year

Jackson, ML., Chung, JR., Jackson, LA., Phillips, CH., Benoit, J., Monto, AS., et al. (2017) Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season. N Engl J Med. 377(6): 534-543.

Cowling, BJ., Chan, KH., Fang, VJ., Cheng, CK., Fung, RO., Wai, W., (2009) Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med, 151(7): 437-446.

https://www.elibrary.ru/item.asp?id=39389452 (access 15/10/2021)

Graphical abstract

Published

2026-02-14

Issue

Section

Articles